PQMD 2021 Global Health Policy Forum:
The Planet, Pandemics and Possibilities
Global Health Donations are a catalyst for inclusive development, stakeholder engagement and a contributor to access to medicines and health systems strengthening. This year’s PQMD Global Health Policy Forum theme: Environment, Social and Governance (ESG) is about the expanding integration of corporate responsibility, sustainability practices and responsibilities of global healthcare stakeholders.
This year’s Forum will feature focused sessions with expert panelists providing a broad spectrum of relevant content related to ESG, including the key risk and resiliency factors that impact the long-term sustainability of healthcare delivery and health system strengthening. Tailored to global and public health governance issues and topics, keynotes and panels discussing blended finance, innovation, access and equity, pandemics and global health in the new normal, will feature insights from leading organizations and trusted advisers. Join us to engage, beyond surface-level discussions and share real-world lessons that you can use to accelerate multi-sectoral and multi-stakeholder action.
We are thrilled to be able to offer this virtual event free of charge.
Please note: All times are Eastern Standard Time (EST)
9:00 – 9:30 AM Meet & Greet Networking Session
Check in by 9:05 AM to be entered into our drawing for an exciting prize!
9:30 – 9:40 AM Welcome
Elizabeth Ashbourne, Executive Director, PQMD
9:40 – 10:10 AM Keynote: Robert L. Mallett, Chief Executive Officer, Rabin Martin
Aligning Business Purpose with NGO Access and Impact: Driving Sustainable Access to Quality Health Care
10:15 – 10:55 AM ESG – Environment
Climate Change • Social Determinants of Health • Disaster Response • Future Trends and Emerging Global Priorities
- Moderator: Kelly S. Willis, Managing Director, Malaria No More
- Dr. Paul Auerbach, Redlich Family Professor Emeritus of Emergency Medicine, Stanford University
- Kris Morico, VP, Environment, Health and Safety & Sustainability, Baxter
- Dr. Mesfin Loha, Country Director, World Vision, South Sudan
11:00 – 11:50 AM ESG – Social
Health Disparities • Social Business Models • Public/Private Partnerships
- Moderator: Verónica Arroyave, Senior Director of Global Community Relations and Executive Director, Baxter International Foundation
- Tiffany Benjamin, President, Eli Lilly Foundation
- Christine Brueschke, Sustainable Investing Analyst, Fidelity International
- Prof. Andrew Ullmann, Member of Parliament in the German Bundestag and City Councillor of Würzburg – Member of Health Committee and Subcommittee on Global Health
- Carmen Villar, VP Social Business Innovation, Merck
11:55 AM – 12:35 PM ESG – Governance
Global Pandemic Coordination • New Economic and Access to Medicine Models • Supply Chain and Distribution • Increased Health Spending
- Moderator: Mark Chataway, Co-Chairman, Baird’s CMC / Hyderus Consulting
- Craig Arnold, VP, Healthcare Sales, UPS
- Claudia Carravetta, VP, CR & Global Philanthropy, AbbVie
- Jane Nelson, Director, Corporate Responsibility Initiative, Harvard Kennedy School
12:40 – 1:10 PM Breakout Sessions
10:00 – 10:30 AM Meet & Greet Networking Session
Check in by 10:05 AM to be entered into our drawing for an exciting prize!
10:30 – 11:00 AM Keynote: Muhammad Ali Pate, Global Director for Health, Nutrition and Population, World Bank
11:05 – 11:45 AM Finance
Financing the new normal: addressing the gaps in the global access to healthcare
- Moderator: Mark Chataway, Co-Chairman, Baird’s CMC / Hyderus Consulting
- Michael Anderson, CEO, MEDACCESS Guaranteed Limited
- Laura Frigenti, Global Head IDAS Institute, KPMG
11:50 AM – 12:25 PM Tech Talks (TT)
Learn about exciting new initiatives and technological innovations designed to address to access to quality healthcare.
- TT1: Sharon Allen, Executive Director, World Telehealth Initiative
- TT2: Dr. Sanjeev Arora, Director and Founder, Project ECHO and Distinguished Professor of Medicine at University of New Mexico
12:30 – 1:00 PM Innovation
Innovation-driven healthcare: Telehealth & Telemedicine – A conversation with:
- Interviewer: Robert L. Mallett, Chief Executive Officer, Rabin Martin
- Martin Edlund, CEO, Malaria No More
- Dr. Mel Spigelman, CEO, TB Alliance
1:05 – 1:45 PM Equity
Innovative Strategies for addressing the Challenges of Health Equity & Disparities: Local, National, Global
- Moderator: Denise Gray-Felder, President, Communication for Social Change Consortium
- Dr. Helene Gayle, President and CEO, The Chicago Community Trust
- Caroline Roan, Chief Sustainability Officer, Pfizer Inc. | Vice President, Global Health & Social Impact, Pfizer Inc. and President, The Pfizer Foundation
1:45 – 2:30 PM Networking Lounge
Come meet peers, partners and new people at the end of an exciting day!
9:00 – 9:30 AM Meet & Greet Networking Session
Check in by 9:05 AM to be entered into our drawing for an exciting prize!
9:30 – 10:00 AM Keynote: Dr. Peter Hotez, Dean of the National School of Tropical Medicine and Professor of Pediatrics and Molecular Virology & Microbiology at Baylor College
10:00 – 10:45 AM Pandemics
COVID-19: How it has changed the way the world responds to current and future pandemics
- Moderator: Mark Chataway, Co-Chairman, Baird’s CMC / Hyderus Consulting
- Pascal Barollier, Managing Director, Public Engagement & Information Services, Gavi, the Vaccine Alliance
- Arnaud Bernaert, Head of Global Health and Healthcare, WEF
- Dr. Isabelle Deschamps, Head of Global Vaccines Public Affairs, Sanofi Pasteur
- Dan Irvine, Senior Director, Health and Nutrition, World Vision
10:45 – 11:15 AM Breakout Sessions
11:20 AM – 12:00 PM Access & Equity
Building back better: Vaccines for the last mile and conflict country challenges
- Facilitator: Carolyn Hall, Access to Care in LMICs Consultant
- Kami Dar, CEO, Uniti Networks
- Valentine Gandhi, Founder and Board Chair, The Development Café
- Ruchika Singhal, Vice President, Global Health, MedtronicLabs
12:05 – 12:45 PM Resilience
Economic Development as a Sustainability Strategy • Supply Chain Infrastructure Challenges and Collateral Needs • Creating Policy to Address Global Pandemics, Global Populations, Health Workforce and Facilities
- Moderator: Verónica Arroyave, Senior Director of Global Community Relations and Executive Director, Baxter International Foundation
- Scott Dubin, Supply Chain, Private Sector Engagement Specialist, Global Fund
- Michael Nyenhuis, CEO, UNICEF USA
- Dr. Kate Tulenko, CEO and Founder, Corvus Health
- Andy Wilson, Vice President, Abbott Fund Tanzania; Director, Global Citizenship, Abbott
MEET OUR SPEAKERS
Robert L. Mallett- Chief Executive Officer, Rabin Martin
As CEO, Robert Mallett brings a unique mix of skills to Rabin Martin gained through three decades of experience in the public sector, private sector, and civil society. At Rabin Martin, Robert is a chief strategist whose commitment to growth and diversity works to bolster client efforts to reach underserved populations. He specializes in:
- Designing innovative programs and ensuring seamless implementation to advance global health objectives
- Spearheading portfolio diversification and stakeholder outreach to reflect the broad dynamics of the health ecosystem
- Applying a health equity lens to analyze and solve pressing public health challenges
Robert’s career has spanned major stints in the public, private, and nonprofit sectors, where he has been at the vanguard of leadership and management changes. Most recently, Robert served as President and CEO of Africare, a leading non-governmental organization committed to improving the quality of life of the people in Africa. He has been City Administrator and Deputy Mayor of Washington, DC. He has also served as Deputy Secretary and Acting Secretary of the Department of Commerce in the Clinton Administration, where he championed issues of diversity and inclusion and embraced the need for more assertive American leadership on the African continent.
In the private sector, Robert is well-known for promoting mission-critical initiatives to broaden the base of support for pharmaceutical innovation and serve patient populations in every corner of the globe. At Pfizer, he led major program initiatives including: the Infectious Diseases Institute in Uganda; International Trachoma Initiative; Pfizer’s Global Health Fellows Program; a malaria grants program in Africa; regional cancer care programs in Europe, South America, and Asia; and a U.S. Southern HIV/AIDS Outreach Program; among others.
Muhammad Ali Pate- Global Director for Health, Nutrition and Population at the World Bank Group and Director of the Global Financing Facility for Women, Children and Adolescents (GFF)
Muhammad Ali Pate is the Global Director, Health, Nutrition and Population (HNP) Global Practice of the World Bank and the Director of Global Financing Facility for Women, Children and Adolescents (GFF), based in Washington DC. Dr. Pate was until recently the Chief Executive Officer of Big Win Philanthropy, based in the UK, and prior to that held several senior positions, including that of Minister of State for Health in the Federal Republic of Nigeria. He was previously in the World Bank Group where he joined as a Young Professional in 2000 and worked on health issues in several regions including Africa and the East Asia and Pacific.Dr. Pate is an MD trained in both Internal Medicine and Infectious Diseases, with an MBA from Duke University. Prior to this he studied at the University College London. He also has a Masters in Health System Management from the London School of Hygiene & Tropical Medicine, UK.
Peter J. Hotez, M.D., Ph.D.- Dean of the National School of Tropical Medicine and Professor of Pediatrics and Molecular Virology & Microbiology at Baylor College of Medicine
Dr. Hotez is also the Co-director of the Texas Children’s Center for Vaccine Development (CVD) and Texas Children’s Hospital Endowed Chair of Tropical Pediatrics and University Professor at Baylor University, Fellow in Disease and Poverty at the James A Baker III Institute for Public Policy, Senior Fellow at the Scowcroft Institute of International Affairs at Texas A&M University, Faculty Fellow with the Hagler Institute for Advanced Studies at Texas A&M University, and Health Policy Scholar in the Baylor Center for Medical Ethics and Health Policy.
Dr. Hotez is an internationally-recognized physician-scientist in neglected tropical diseases and vaccine development. As head of the Texas Children’s CVD, he leads a team and product development partnership for developing new vaccines for hookworm infection, schistosomiasis, leishmaniasis, Chagas disease, and SARS/MERS/SARS-2 coronavirus, diseases affecting hundreds of millions of children and adults worldwide, while championing access to vaccines globally and in the United States. In 2006 at the Clinton Global Initiative he co-founded the Global Network for Neglected Tropical Diseases to provide access to essential medicines for hundreds of millions of people
He obtained his undergraduate degree in molecular biophysics from Yale University in 1980 (phi beta kappa), followed by a Ph.D. degree in biochemistry from Rockefeller University in 1986, and an M.D. from Weil Cornell Medical College in 1987. Dr. Hotez has authored more than 500 original papers and is the author of four single-author books, including Forgotten People, Forgotten Diseases (ASM Press); Blue Marble Health: An Innovative Plan to Fight Diseases of the Poor amid Wealth (Johns Hopkins University Press); Vaccines Did Not Cause Rachel’s Autism (Johns Hopkins University Press); and a forthcoming 2020 book on vaccine diplomacy in an age of war, political collapse, climate change and antiscience (Johns Hopkins University Press).
François Bompart, MD- Access Committee Chair of the Drugs for Neglected Diseases initiative (DNDi), a non-profit organisation based in Geneva, Switzerland
Most of his professional life was spent within the Sanofi group in a variety of positions in clinical research and medical affairs in Europe and the USA. In 2005, he joined the Sanofi Access to Medicines department which he directed prior to moving to DNDi in 2018 on a pro bono basis. He chaired the Global Health Initiative of the EFPIA (European Federation of Pharmaceutical Industries and Associations) from its creation in 2012 until 2017.
His has worked for over 25 years in anti-infective medicines and vaccines, with a focus on emerging and developing countries. His main fields of interest are related with access to care in resource-limited countries, as well as ethical issues in clinical research for vulnerable populations.
François Bompart received his MD from the University of Angers (France) and trained in Clinical Pharmacology at University College London (UK) and Hôpital Cochin in Paris (France).
Craig Arnold – Vice President of Healthcare Sales, UPS
Craig Arnold is a VP of Healthcare Sales for UPS responsible for international business development. In addition to his day job, Craig has deployed as a front-line responder into disaster sites to help coordinate front-line relief logistics after cyclones, hurricanes, and earthquakes in locations around the globe.
Craig joined UPS in 1987, and has held sales positions in the U.S., Australia, Malaysia, and throughout Europe.
In field deployments, in addition to volunteering with the Salvation Army, Craig has been the first UPS person on the scene and worked as a liaison to The UPS Foundation.
Craig has a Bachelor’s Degree in Marketing from DePaul University and a Master’s Certificate in Project Management from George Washington University. He has served as a Board Member and as Vice Chair on the North California Salvation Army Advisory Board, was Chairman of The Salvation Army Kroc Center in San Francisco for four years, and is currently an Advisory Board Member for The Metro Atlanta Salvation Army.
Craig is married with three children.
Elizabeth (EJ) Ashbourne – Executive Director, PQMD
As Executive Director of PQMD, Elizabeth (EJ) Ashbourne is responsible for furthering PQMD’s commitment to championing and advancing standards in medical supply and service donations by developing the vision, strategy, and execution of the organizations five pillars of work.
Prior to joining PQMD, EJ was most recently the Managing Partner for EJA Consulting, a small private firm specializing in strategic planning, fundraising, international development and joint venture support, mission driven event management, and all aspects of non-profit turn-around. Prior to that, EJ spent 17 years at the World Bank in a number of senior level positions, in the areas of private sector partnerships, global public health, infectious disease, and health management information systems.
Additionally she was a senior operations officer in the Office of Corporate Reform and Human Resources. In the area of health, EJ held the position of Lead, Global Health Information Programs for the World Bank and the Health Metrics Network at the World Health Organization; led the work on eHealth and mHealth in the Health Anchor of the Bank, and contributed to research on a common metric for donor agencies, development partners and countries to measure their investment in health information. At the World Bank, she also spent many years working closely on issues specific to engaging the private sector in the fight against HIV/AIDS as the focal point for private sector partnerships with the World Bank’s Africa Region HIV/AIDS programs. Her role was to develop and implement the mechanisms through which the private sector can access financial and technical resources from the Bank’s initial 2billion dollar investment in HIV/AIDS.
She has also worked for World Learning as a Country Director, overseeing a wide range of USAID capacity building programs in Eastern Europe and served as senior coordinator for international cooperative education programs at American University among other positions. EJ holds an MA in International Education, with an emphasis on Organizational Management from American University in Washington, DC and a BSc in Communications and History from Ithaca College, Ithaca, NY.
Paul S. Auerbach, MD, MS, FACEP, MFAWM, Redlich Family Professor Emeritus, Stanford University School of Medicine
Paul S. Auerbach, MD, MS, FACEP, MFAWM is the Redlich Family Professor Emeritus in the Department of Emergency Medicine at the Stanford University School of Medicine, and Adjunct Professor of Military/Emergency Medicine at the F. Edward Hébert School of Medicine of the Uniformed Services University of the Health Sciences. He is co-author of Enviromedics: The Impact of Climate Change on Human Health, editor of the textbook Wilderness Medicine, and author of Medicine for the Outdoors. Dr. Auerbach is a founder of the Wilderness Medical Society, member of the Council on Foreign Relations, and serves on the National Medical Committee for the National Ski Patrol System. He was a first responder to the earthquakes in Haiti (2010) and Nepal (2015) and is visiting scholar at the National Center for Disaster Medicine and Public Health.
Tiffany R. Benjamin – Senior Director, Social Impact and President of the Eli Lilly and Company Foundation
Ms. Benjamin is Senior Director, Social Impact and President of the Eli Lilly and Company Foundation. In this role, she manages the company’s corporate social responsibility efforts, disaster relief efforts, global health initiatives, Environmental, Social and Governance strategy, and community civic engagement. In 2020, she led the company’s global philanthropic efforts in response to the COVID-19 pandemic as well as its philanthropic efforts to address racial inequity in the United States. Prior to this role, she was Senior Director, Litigation and Legal Compliance at Eli Lilly and Company. In that role, she headed the company’s non-patent litigation group, managing the company’s product liability, complex commercial, and human resources litigation. From 2015 to 2017, she served as the company’s Assistant General Counsel, Assistant Corporate Secretary. In that role, she served as the company’s securities counsel and corporate governance counsel, as well as assistant secretary to the Board of Directors. From 2013 to 2015, she served as the company’s anti-corruption counsel and legal counsel on the company’s privileged internal investigation process.
Prior to joining Lilly, Ms. Benjamin served as Senior Investigative Counsel for the Democratic Staff of U.S. House of Representatives Energy and Commerce Committee, working on investigations into national matters including the Deepwater Horizon oil spill, the Wal-Mart Mexico bribery allegations, and the 2012 fungal meningitis outbreak. Before joining the Committee, she worked as an attorney in the D.C. office of King and Spalding, as a member of its Special Matters team, handling white collar matters and government investigations. Ms. Benjamin has a law degree from Harvard Law School and an undergraduate degree from Indiana University.
Christine Brueschke, Sustainable Investing Analyst, Fidelity International
Christine is a financial services professional with approximately twenty years of experience in investment analysis. As a member of the Sustainable Investing team at Fidelity International, she works on a variety of ESG matters: particular areas of focus currently include healthcare, tech, consumer staples and sustainable brands, and environmental and regulatory reporting.
Christine has worked in a range of industry sectors across Europe, the US and Asia. She previously worked as a Principal and Senior Equity Research Analyst for investment banks including JPMorgan/Chase H&Q, where she advised institutional clients on investment strategies, as well as corporate clients on IPO’s and acquisitions. Prior to this, she worked as a telco executive, establishing and managing the Moscow, Russia office for a large US telecoms company. She has also worked in Business Development with an independent financial advisor, Beeson & Co, and with the University of Oxford’s Saïd Business School.
Christine serves on the Board of Trustees of Chautauqua Institution, the historical seat of lifelong learning in America. She earned an MBA from Stanford University and a BA cum laude from Yale University.
Claudia Carravetta- Vice President, Corporate Responsibility & Global Philanthropy at AbbVie
In this capacity, she is responsible for overseeing AbbVie’s Corporate Responsibility and Philanthropy strategies and initiatives – including Environmental, Social and Governance (ESG), employee and community engagement, patient access and independent medical and patient education—to advance the company’s sustainability, reputation and corporate citizenship. Claudia previously was the head of External Affairs for Japan, Emerging Markets, and Australia (JEM&A) business, where she advanced public policy solutions to improve patient access to innovative medicines across LATAM, EEMEA and JAPAC. She previously led AbbVie’s Government Affairs Therapeutic Area Strategies team, overseeing alliance development, policy public affairs campaigns, and advocacy in support of priority therapeutic areas.
Prior to joining AbbVie, Claudia served in positions in both international and US public affairs at Pfizer in New York. She also spent several years at Orbis International, an international public health NGO, where she worked with country programs in South and Southeast Asia and in Africa to empower local communities to address avoidable blindness through training and collaboration. Early in her career, Claudia was a legislative aide in New York’s Suffolk County Legislature.
Claudia holds an MBA from NYU’s Stern School of Business, an MA from University of Warwick in the United Kingdom, and a BA from McGill University in Canada.
Mark Chataway- Director, Hyderus Cyf
Mark Chataway is an expert in policy analysis and development, opinion research and communications. Mark has worked for governments such as the European Commission, Switzerland and South Africa; for intergovernmental organisations such as the Global Fund, the IBSA alliance, Gavi and the WHO; for academic institutions including Johns Hopkins Bloomberg School of Public Health, the London School of Hygiene and Tropical Medicine and RAND; for non-governmental groups such as the Bill & Melinda Gates Foundation and PATH and; for all of the world’s major vaccine research and production companies. Mark is the Director of Hyderus, a consultancy based in Ireland and is co-chairman of Baird’s CMC, a global consultancy group owned by 47 shareholders in over 38 countries.
Dr. Mesfin Loha, Country Director in South Sudan, World Vision International
Dr. Mesfin Loha has over 30 years of experience in leadership and management, particularly in public health, including maternal and child health, HIV&AIDS and Nutrition. Mesfin served in World Vision for more than twenty years in various capacities, including a role of regional director for programs and strategy.
In his current role as country director in South Sudan, Mesfin provides overall strategic and operational leadership to WV’s programs serving over 1 million children and vulnerable communities.
Prior to World Vision, Mesfin has served with the Ministry of Health in Ethiopia, holding various positions including leading the North Gondar zone health department. He has also served with the Ethiopian Evangelical Church Mekane Yesus as the health and nutrition program coordinator.
Mesfin holds a Doctor of Medicine (MD) degree from Addis Ababa University, Gondar College of Medical Sciences and a Masters in public Health from the Univesite Libre de Bruxelles.
Jane Nelson- Director, Corporate Responsibility Initiative, Harvard Kennedy School
Jane Nelson is the founding director of the Corporate Responsibility Initiative at Harvard Kennedy School and a nonresident senior fellow at the Brookings Institution. She serves on the boards of directors of Newmont and Chevron’s Niger Delta Partnership Initiative, and on advisory councils for Abbott, Bank of America, ExxonMobil, Griffith Foods, APCO Worldwide and the Sustainable Agriculture Initiative platform. She is a member of the World Economic Forum’s Stewardship Board for Food Systems, and she serves on WEF’s Global Future Council on Transparency and Anti-Corruption. She has previously been on advisory councils for the IFC and InterAction, among others, and served as a senior associate with the Institute for Sustainability Leadership at Cambridge University and a track leader and adviser with the Clinton Global Initiative. She has co-authored five books and over 100 publications on corporate responsibility and public-private partnerships.
From 1993 to 2012, Nelson was a director and senior adviser at the International Business Leaders Forum, created in 1990 by HRH The Prince of Wales and a group of business leaders to promote responsible business practices and partnerships. In 2001, she worked with the UN Global Compact in the office of the UN Secretary-General writing a report for the General Assembly on cooperation between the United Nations and the private sector. Prior to 1993, Nelson worked for the World Business Council for Sustainable Development in Africa, for FUNDES in Latin America, and as a vice president at Citibank working for the bank’s Financial Institutions Group in Asia, Europe, and the Middle East. She is a former Rhodes Scholar, 2016 Arthur Vining Davis Aspen Fellow, recipient of the Keystone Center’s 2005 Leadership in Education Award, and co-recipient with David Grayson of the 2015 Best Book Award in the Social Issues in Management division at the Academy of Management.
Andrew Ullmann, Member of Parliament in the German Bundestag and City Councillor of Würzburg
A physician by training, Ullmann is a Spokesperson for the Health Committee and Vice-Chair for the Sub-Committee on Global Health. Ullmann has a background in infectious diseases from Harvard Medical School and Clinic Mainz University, where he also teaches at the University’s Hospital in Würzburg.
Andrew Ullmann is one of the most active names in global health within the German Parliament. He plays a pivotal role in both local and national politics to secure leadership towards eliminating infectious diseases.
Andrew Ullman is a member of UNITE since October 2019.
Kelly S. Willis, Managing Director, Malaria No More
Kelly S. Willis is a global health professional with 25 years of experience in both public- and private-sector healthcare and development, worldwide. Kelly is currently Managing Director at Malaria No More, leading the design of innovative approaches to ultimately eradicating one of the world’s oldest diseases. Before establishing Willis Solutions, providing strategic and management consulting services to the global health community, Kelly led the Global Public Health division of the United States Pharmacopeia, assisting drug manufacturers and regulatory agencies around the world to
ensure access to quality medicines, and protect against counterfeit and substandard drugs. Before that, Ms. Willis served as Executive Director at Accordia Global Health Foundation, launching and sustaining Centers of Excellence in Health throughout sub-Saharan Africa, to build permanent
capacity for health innovation and leadership on the continent. Kelly’s career also included a decade in the pharmaceutical sector, most notably with senior management positions at Pfizer, in a range of disciplines across corporate finance, supply chain management, health and economic policy, and corporate social responsibility. She holds BA and MBA degrees from Michigan State University, where she was recently presented the university’s Distinguished Alumni Award.
Sharon Allen – Executive Director, World Telehealth Initiative
Sharon Allen is the co-founder and Executive Director of World Telehealth Initiative (WTI). As a recognized leader in international philanthropic telehealth, Sharon is often invited to speak at notable conferences, including American Telehealth Association, the White House Telehealth Innovation Summit, Nigeria’s Healthcare Today – Keynote, MENA Telehealth Conference, Telehealth Innovator’s Forum, AAFP Global Health Summit, and more. She has traveled extensively to understand the needs of low-resourced healthcare clinics and hospitals worldwide. Under her leadership, WTI has developed an innovative model that leverages remote philanthropic physicians to provide sustainable medical expertise via telehealth. Since its founding in 2017, WTI has established remote specialist care and training to onsite providers in 18 under-served communities throughout the world.
Sharon has been selected to serve on the World Health Organization Digital Health Board of Advisors and Roster of Experts. She is currently working with WHO on their Telehealth Roadmap for the Underserved.
Michael Anderson- Chief Executive Officer & Board Member, MedAccess
Michael has overall lead on strategy, partnerships, and delivery at MedAccess. Prior to joining MedAccess in 2017 he was CEO at CIFF (the Children’s Investment Fund Foundation) and Director General at the UK Department for International Development. He has served as the Prime Minister’s Special Envoy on the SDGs, on the UN Commission for Life‐Saving Commodities, and various committees for the UN, World Bank, G7, G20, and OECD.
He was a founder owner of Bazian, a company specialising in Evidence Based Medicine, and had a legal career for 15 years specialising in cross‐border litigation.
Michael has held academic posts at SOAS and the LSE and was made a Companion in the Order of the Bath in 2014 for his services to international development.
Sanjeev Arora, MD, FACG, MACP – Director and Founder, Project ECHO (Extension for Community Healthcare Outcomes)
Sanjeev Arora, MD, MACP, FACG is a Distinguished and Regents’ Professor of Medicine with tenure in the Department of Internal Medicine at University of New Mexico Health Sciences Center. Project ECHO® (Extension for Community Healthcare Outcomes) dramatically improves both capacity and access to specialty care for rural and underserved populations by linking expert inter-disciplinary specialist teams with primary care clinicians through teleECHO™ clinics, in which the experts mentor primary care clinicians to help them manage their patient cases and share their expertise via mentoring, guidance, feedback and didactic education. This helps rural clinicians develop knowledge and self-efficacy so they can adopt research findings and deliver best practice care for complex and chronic health conditions.
Kami Dar- Co-founder and Chief Executive of Uniti Networks
Kami is an impact-focused leader and expert on systems, automation, data analytics, and talent management inthe global development and impact sector. He is currently Co-founder and Chief Executive of Uniti Networks, astartup seeking to accelerate digital service adoption among the bottom billion with a focus on equitable access and impact.
Previously, Kami served as Co-founder and innovator-in-chief at the media platform for global development,Devex, where he spent nearly two decades leading a team of analysts, researchers, engineers, and designers to deliver the world-class technologies that made Devex the definitive hub for more than a million development professionals.
He has worked closely with external development partners, including Oxfam and the World Bank, and tackled complex integrations and strategic alignment with a diverse group of technology partners and platforms ranging from ERP and analytics to agile management and algorithmically-driven solutions for mapping of development activities.
Earlier, Kami worked on systems consulting and product deployment with the US Government at a large technology consulting firm. He subsequently worked on the design and development of a monitoring & evaluation (M&E ) platform for a $54 million USAID program.
Kami advises organizations engaged in large-scale system change in pursuit of the the Global Goals. He continues to serve on the Board of Directors of Devex and additionally services on the European Board of WorldReader — a leader in digital reading in under-served communities worldwide — and the board of AfricaWorks, a non-profit working to support expertise and talent on the African continent.
Martin Edlund, CEO, Malaria No More
Martin Edlund is a founding member and Chief Executive Officer of Malaria No More. During his tenure at Malaria No More, he has led strategies to mobilize billions of dollars in global resources from governments and private investors for innovative global health programming. Edlund lived and worked in West Africa as Malaria No More’s Director of New Programs, where he helped launch novel net distribution, testing and health
education campaigns with country leadership and mobile/media partners in Senegal, Cameroon, Tanzania, and Chad. Martin is a frequent contributor to thought-leader media coverage including CNN, The Times of India, The Guardian, The Telegraph, Fox News, and other outlets. Prior to joining MNM, he was a journalist for The Wall Street Journal, The New York Times, and The New Republic, among other publications, and a political consultant in Washington, D.C., specializing in online campaign strategies. He is a graduate of Harvard University.
Laura Frigenti- Global Head, International Development Assistance Services Institute
Laura is an international senior executive with strategic and managerial leadership skills with international, non-profit, government and economic (World Bank and UN) organizations, including at the Cabinet level. She has in-depth knowledge and expertise of Africa, Central Asia, Europe and Latin America markets, with direct experience in dealing with political and business leaders in over 30 countries. She has delivered advisory services and lending products to governments, both directly managing the transactions (over $10B) and in supervisory roles (~$10B per annum) over 25+ years.
Dr. Helene D. Gayle- President and CEO of The Chicago Community Trust
Helene D. Gayle has been president and CEO of The Chicago Community Trust, one of the nation’s oldest and largest community foundations, since October 2017. Under her leadership, the Trust has adopted a new strategic focus on closing the racial and ethnic wealth gap in the Chicago region.
For almost a decade, Dr. Gayle was president and CEO of CARE, a leading international humanitarian organization. An expert on global development, humanitarian and health issues, she spent 20 years with the Centers for Disease Control, working primarily on HIV/AIDS. She worked at the Bill & Melinda Gates Foundation, directing programs on HIV/AIDS and other global health issues. She also launched the McKinsey Social Initiative, a nonprofit that builds partnerships for social impact.
Dr. Gayle was born and raised in Buffalo, NY. She earned a B.A. in psychology at Barnard College, an M.D. at the University of Pennsylvania and an M.P.H. at Johns Hopkins University. She has received 18 honorary degrees and holds faculty appointments at the University of Washington and Emory University. She serves on public company and nonprofit boards, including The Coca-Cola Company, Colgate-Palmolive Company, Go Health, Brookings Institution, Center for Strategic and International Studies, New America, ONE Campaign, Federal Reserve Bank of Chicago, and Economic Club of Chicago. She is a member of the American Academy of Arts and Sciences, Council on Foreign Relations, American Public Health Association, National Academy of Medicine, National Medical Association, and American Academy of Pediatrics. She has authored numerous articles on global and domestic public health issues, poverty alleviation, gender equality, and social justice.
Denise A. Gray-Felder, APR- Founding President of Community for Social Change Consortium
Denise is the founding president of Communication for Social Change Consortium (www.cfsc.org) – a global non-profit organization she launched in 2003 with a major grant from The Rockefeller Foundation. She oversees this organization known for its community-based participatory approaches, ground-breaking publications, support to top executives, counsel, network of practitioners and advocacy. (The CFSC Consortium is a non-profit organization in the United States and a registered charity in the United Kingdom and Wales.)
Denise Gray-Felder is a global communication leader who has worked in multiple industries in 50+ countries addressing some of the world’s most difficult health challenges such as disparities in health care, neglected tropical diseases, sickle cell disease, access to medicines, vaccine hesitancy, vaccine uptake (covid-19, polio, influenza, HIV-AIDS vaccine research, childhood diseases), tuberculous, safe abortions, reproductive health, covid pandemic and Ebola preparedness. She has managed global communication for critical issues in developing countries such as access to medicines/health care, polio vaccines, HIV/AIDS, gender-based violence, income and poverty alleviation, subsistence farming, child safety, water and sanitation, disaster relief, livelihoods, climate, racial polarization and food insecurity. She currently serves on three covid-19 focused groups; the (U.S.) National Academies of Sciences, Engineering and Medicine, NY State Health Foundation and the Center for Strategic and International Studies.
Caroline Roan- Chief Sustainability Office and Vice President of Global Health & Social Impact at Pfizer Inc., President, The Pfizer Foundation
Caroline Roan is Chief Sustainability Officer and Vice President of Global Health & Social Impact at Pfizer Inc. and is President of The Pfizer Foundation. Caroline oversees Environmental, Social and Governance (ESG) and global health work across Pfizer to help build a healthier, more prosperous, more sustainable world for all.
Together with her global team, Caroline leverages the full scope of Pfizer’s resources to advance environmental, social and governance issues – ranging from redefining how Pfizer fights infectious disease to efforts to reduce greenhouse gas emissions to expanding affordable access to Pfizer’s breakthrough medicines and vaccines.
Prior to joining Pfizer, Caroline worked on the Robert Wood Johnson Foundation’s Community Health Team, which focused on promoting individual and community health by increasing social support and connection. She also served as Associate Director of the Center for Interdisciplinary Research on AIDS (CIRA) at Yale University’s Department of Epidemiology and Public Health.
She currently serves on the U.S. Global Leadership Campaign, the advocacy arm of the U.S. Global Leadership Coalition. Caroline received her Bachelor of Arts in sociology and anthropology from Earlham College, Richmond, Indiana, and her Master of Public Policy from the School of International and Public Affairs, Columbia University.
Dr. Mel Spigelman- President and Chief Executive Officer, Global Alliance for TB Drug Development
Dr. Spigelman is the President and Chief Executive Officer of the Global Alliance for TB Drug Development (TB Alliance), and a Member of its Board of Directors. Prior to being appointed President and CEO in 2009, Dr. Spigelman served for five and a half years as the Director of Research & Development at TB Alliance. He was instrumental in forging key organizational partnerships and building the pipeline of TB drug candidates. Notably, Dr. Spigelman was a leader in developing a regimen-based paradigm of TB drug development – a faster and more efficient approach, which is emerging as the gold standard within the TB drug research field.
Dr. Spigelman spent a decade managing drug R&D at Knoll Pharmaceuticals (a division of BASF Pharma) prior to joining TB Alliance. As Vice President of R&D at Knoll for eight years, Dr. Spigelman supervised all R&D activities from basic discovery to regulatory approval and Medical Affairs. He established global R&D processes as part of Knoll’s senior R&D management team, oversaw a marked increase in US regulatory filings and approvals, and supervised joint R&D programs with multiple other pharmaceutical companies.
Dr. Spigelman received his undergraduate degree from Brown University and his medical degree from the Mt. Sinai School of Medicine where he specialized in Internal medicine, Neoplastic Diseases and Preventive Medicine. Dr. Spigelman holds board certifications from the American Board of Internal Medicine, the American Board’s Subspecialty Board of Medical Oncology, and the American Board of Preventive Medicine and was the recipient of the American Cancer Society Clinical Oncology Career Development Award (1985-1988).
Presently, Dr. Spigelman is Co-Chair of the Working Group on New Drugs of the WHO Stop TB Partnership.
Verónica Arroyave, Senior Director of Global Community Relations and Executive Director, Baxter International Foundation
Verónica Arroyave is the Senior Director of Global Community Relations and Executive Director of the Baxter International
Foundation. In that capacity, she works to advance the company’s mission to save and sustain lives by building global philanthropic partnerships to increase access to healthcare for the underserved, to develop the next generation of innovators who will lead the way in advancing healthcare and to create a long-lasting impact in Baxter’s communities. Additionally, she advances Baxter’s commitment as a socially responsible company by serving as the co-chair of Baxter’s Global Corporate Responsibility Council.
Veronica has held several leadership roles in the corporate, government, and non-profit sectors catalyzing global health partnerships with leading global healthcare companies and humanitarian organizations. Veronica has a bachelor’s degree from Our Lady of Holy Cross College, a master’s degree from Tulane University’s School Public Health & Tropical Medicine and a doctorate from Virginia Tech’s School of Public and International Affairs.
Pascal Barollier, Public Engagement & Information Services, Gavi, the Vaccine Alliance
Pascal Barollier is Gavi’s Managing Director of Public Engagement & Information Services, a team of dedicated advocacy and public policy, knowledge management and technology solutions, and communications professionals.
Before joining Gavi in 2013, Pascal was Vice President of global external communications at Sanofi Pasteur, one of the largest global vaccine manufacturers. He also coordinated Sanofi’s global communications during the 2009-2010 influenza pandemic.
Previously, Pascal was a journalist for Agence France-Presse (AFP) for 18 years from Paris, Washington, DC, and other locations around the world.
Pascal has co-founded a magazine and web agency specialised in digital content. He is the author of three novels published by Flammarion, co-author of an essay about life in Sarajevo during the war in the former Yugoslavia and co-scriptwriter of the movie Aime ton père starring Gérard and Guillaume Depardieu.
Arnaud Bernaert- Head of Health and Healthcare, Member of the Executive Committee, World Economic Forum
An MBA graduate from HEC, Arnaud Bernaert dedicated his prolific career to strategy, partnerships, M&A and Healthcare policy matters. He also published extensively on those themes and received significant media coverage. This he has done first as a senior executive in multinational organizations such as Baxter and Philips Healthcare, then as the Global Head for Health and Healthcare Industries at the World Economic Forum. Arnaud Bernaert has a unique understanding of Global Health and Healthcare challenges. He also maintains deep personal connections within a unique network of industry CEO’s, policy makers, regulators, heads of international organizations and civil society leaders.
As a member of the Executive Committee of the World Economic Forum, Arnaud Bernaert has launched defining public private coalitions in fields as diverse as epidemics preparedness, vaccines and antibiotic innovation, value based healthcare, precision medicine regulations, access to primary care, payment reforms, healthcare IT just to name a few. On such matters and many others, he also addressed as key note speaker, panellist, moderator or knowledge expert the participants of the most prestigious global healthcare gatherings in Davos, UNGA, Forbes conferences, World Health Assembly week, World Health summit and many other conferences.
Isabelle Deschamps, PhD.- Head of Global Vaccines Public Affairs- SANOFI PASTEUR
Isabelle has been Head of Global Public Affairs at Sanofi Pasteur since June 2018.
Isabelle began her career with Pasteur Mérieux Connaught’s International Medical department more than 20 years ago. She subsequently held various positions in Regulatory Affairs in Asia-Pacific and other international regions where she worked closely with WHO for the prequalification of vaccines. Isabelle then moved to the field of Public Affairs to take over the liaison between Sanofi Pasteur and UNICEF & GAVI, the Vaccine Alliance and to chair the Vaccines Policy Group of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), based in Geneva.
Isabelle has also led the Sanofi Pasteur Public Affairs teams in Africa, the Middle East, Eurasia and South Asia, supporting the interface of countries with global health organizations and key national policy makers involved in the development of immunization policies. In 2016, her scope extended beyond vaccines and she led the Public Affairs activity for Eurasia and the Middle East for the entire Sanofi portfolio (Diabetes, Cardiovascular, Specialty Care, Rare Diseases, Consumer HealthCare and Vaccines).
Isabelle holds a PhD in Biology (University of Burgundy, France).
Scott Dubin- Supply Chain, Private Sector Engagement Specialist with The Global Fund
Scott is a Supply Chain, Private Sector Engagement Specialist with The Global Fund where he creates innovative logistical solutions to ensure the uninterrupted supply of vital health supplies around the world. With a consistent focus in logistics, Scott has over 18 years of experience designing, implementing and managing humanitarian, development and diplomatic projects in a host of complex environments in the U.S. and abroad. In these roles he has worked on behalf of NGOs, private companies, and the U.S. government. Scott recently designed and lead a cutting edge initiative to utilize drone technology for delivering much-needed medicines, lab samples, blood transfusions and vaccines in Malawi. He has also developed a low cost, cloud based, transport management system, called TransIT, for use in low resource settings, which is now being transferred to open source software and becoming a global good. Scott holds a B.A. Business Administration and MSc. International business. He is married and a dad to two little girls.
Valentine (Val) J. Ghandi- Founder, The Development Cafe
Valentine J Gandhi is senior Evaluation, Innovation and Tech4Good specialist, with over 19 years of interdisciplinary experience at both field and policy level. Implementing and leading quantitative and qualitative research, teaching/training and project management, M&E, Strategic consulting, knowledge sharing and capacity building with various UN, CGIAR and Donor agencies. He has developed and led multi country projects on Livelihoods, ICT4D, Health and Climate Smart Ag technologies. He actively promotes innovation in M&E and Research. He is the founder of the think tank The Development CAFÉ , and Co Founder of the NIRAS Data Futures Hub and regularly speaks on the topic of innovations in international development. He is currently the Chief of Party for USAID/Indonesia’s Monitoring, Evaluation and Learning Support program for Social Impact., For more details visit his LinkedIn Profile.
Carolyn (Cali) Hall- Global Head of Patient Access Innovation, Biocon Biologic
As the Global Head of Patient Access Innovation at Biocon Biologic, Carolyn is responsible for enhancing patient access to much needed Biocon Biologics by conceptualizing, driving, and implementing innovate access agreements for quality cancer and diabetes care in LMICs (Middle East & Africa, SE Asia, LATAM, Russia/CIS and Eastern Europe). She also leads the implementation of the company’s flagship “10 Cents” initiative to boost access to comprehensive diabetes management including recombinant humanized insulin for under 10 cents per patient per day.
Carolyn is a passionate and international public health professional with over 30 years international experience in the Pharmaceutical, Biologics & Medical device arena who promotes thought leadership to make a difference to health ecosystems in low income countries. Carolyn is sensitive to and has experience in working with multi-cultural teams and has a great sense of empathy and patient centricity. She is passionate about advocating for better standard care and removing the barriers that stand in the way of optimum patient access in developing counties.
Dan Irvine- Senior Director, World Vision International Health and Nutrition Department
As Senior Director for World Vision International’s health and nutrition department since 2007 Dan has led strategy, implementation and engagement globally. World Vision’s health investments more than doubled in this period, significantly expanding community systems strengthening approaches to reduce maternal and under-five child morbidity and mortality. Those approaches have been largely focused on building community capacity and ownership of their health outcomes, and linking community-based approaches such as Community Health Workers into formal health systems.
Dan is currently Chair for the EBODAC (Ebola Vaccine Deployment, Acceptance and Compliance) Steering Committee, overseeing a large-scale Ebola vaccine trial support program in West and Central Africa, and advises the Global Schistosomiasis Alliance. He has supported World Vision humanitarian responses to the H1N1 pandemic, Zika, HIV and malaria.
Dan lived and worked in Africa for 15 years, with notable stints in the Republic of Congo and Zambia. He holds a BSc. In Community Psychology and an MSc. in Public Policy with focus on post-conflict reconstruction. He has served as an adjunct professor at George Mason University, and has served for 17 years on the Board of Directors for the Elizabeth Bowers Zambia Education Fund.
Michael Nyenhuis- President & CEO, UNICEF USA
Michael grew up Trick-or-Treating for UNICEF and has devoted his life and career to improving the health and well-being of the world’s children and families. Prior to joining UNICEF USA, Michael was the president and CEO of Americares for six years and the CEO of the global nonprofit MAP International for 13 years. A former journalist with a passion for global health, he previously served on USAID’s Advisory Committee on Voluntary Foreign Aid and chaired the board of the Integral Alliance, a global network of faith-based NGOs. He also currently serves on the board of InterAction, the largest coalition of U.S.- based relief and development organizations working internationally, and the leadership council at Concordia, an organization and forum that promotes cross-sector partnerships for social impact. A Minnesota native, Michael holds a Masters in Business Administration from Emory University and Bachelor of Arts in Urban Studies and Communications from University of Wisconsin Green Bay.
Ruchika Singhal- Global Health & Vice President, Medtronic LABS
Ruchika is the fearless leader of Medtronic LABS. Prior to this role, she worked at CR Bard as Vice President, International. Previously she worked at Medtronic for fourteen years in various roles across Strategy, International Market Development, Marketing and New Product Development. Throughout her career, she has developed businesses in emerging markets and pioneered scalable, sustainable business models to address healthcare needs at the bottoms of the economic pyramid.
Ruchika is actively involved in mentoring social businesses and is passionate about healthcare and women’s empowerment.
Ruchika holds a Masters in Biomedical Engineering from Johns Hopkins and an MBA from the University of Chicago, Booth School of Business.
Dr. Kate Tulenko MD, MPH, MPhil, FAAP – CEO and Founder, Corvus Health
Dr. Kate Tulenko is a globally recognized expert in health workforce and health systems, the former Director of the US government’s global health workforce project, and the former coordinator of the World Bank’s Africa health workforce program. She is currently serving as CEO and Founder of Corvus Health, a global health workforce social enterprise that works to increase access to health workers throughout the world through a novel set of approaches including advisory services, HR management, productivity and quality improvement, school expansion, training, and retention. Corvus Health’s clients include hospitals and health systems, medical and nursing schools, insurance companies, the World Bank, Tata Trusts, GE Healthcare, USAID, and private equity firms. Corvus Health’s achievements include assisting the government of Saudi Arabia with the nationalization of its health workforce, the design of the clinical team for the new hospitals of Ireland’s largest health insurer, and the design of the medical simulation lab for Honoris United University, Africa’s largest private university system.
Dr. Tulenko served as Director of CapacityPlus, the US Agency for International Development’s flagship global health workforce project where she was co-Principal Investigator for the World Health Organization’s work to calculate the 18 million global health worker shortage. She has also served as Vice President, Health Systems Innovation, for IntraHealth International, a global health non-profit where she secured IntraHealth status as an NGO in official relations with WHO and represented IntraHealth as an official delegate to the World Health Assembly. She served as coordinator of the World Bank’s Africa Health Workforce Program, working directly with Ministries of Health, Education, and Finance to plan and implement national health workforce strategies.
She has received a Rainer Arnhold Fellowship for innovation in global development, is listed in Women In Global Health’s list of 50 woman experts in Global Health Security; was named one of “300 Women Leaders in Global Health” by the Geneva Graduate Institute of Development Studies, and has published widely, including in the New York Times and Foreign Policy. Dr. Tulenko speaks widely and is an occasional global health commentator of Fox Business News. She recently delivered the inaugural address of the Johns Hopkins School of Public Health Eckhert Fazen Health Workforce Lecture Series, and has served on expert panels for the WHO, the American Hospital Association, the Rockefeller Foundation, and the Aspen Institute. Dr. Tulenko is an experienced Board member and has served on the boards of Corvus Health, VaxSyna (plant-based vaccines), RightRoom (HR), the Global Business School Network, Children’s Heartlink, the National Physicians Alliance, the Dr. Ameyo Stella Adadevoh Foundation, and the Chesapeake Healthcare Foundation. She is a member of the World Economic Forum’s Global Future Council on Longevity and publishes periodically on WEF’s platform. She received her bachelors in biochemistry from Harvard as Phi Beta Kappa class marshal, her masters in history and philosophy of science from Cambridge University, her MD from the Johns Hopkins School of Medicine, and her MPH from the Johns Hopkins School of Public Health where she is an adjunct professor in the Department of Health Systems. She is a committed Rotarian and believes in the power of volunteerism and community service to transform the world. Dr. Tulenko is married with two tween daughters and enjoys art, hiking, and being outdoors.
Andy Wilson, Vice President, Abbott Fund Tanzania; Director, Global Citizenship, Abbott
Andy is Vice President of Abbott Fund Tanzania and Director, Global Citizenship, he is responsible for programs that advance Abbott’s mission to create healthier global communities.
Andy joined Abbott in 1990 and the Abbott Fund in 2004. His work has focused on building collaborative partnerships that expand access to care, around the world. Currently, Andy oversees the strategic direction and operations of a public-private partnership with the Government of Tanzania to strengthen the country’s healthcare system; he also leads programs focused on health access in India and hepatitis eliminaton in Africa and Eastern Europe.
Prior to joining the Abbott Fund, Andy worked in Abbott’s diagnostics business. Andy has a B.A. in Political Science from Becknell University.